title: Safety and efficacy of low-potassium dialysate.
abstract: To evaluate the safety and efficacy of low-potassium dialysate, 11 patients with stable end-stage renal disease and with no history of arrhythmia or digitalis use were studied. All were treated with hemodialysis three times per week. Dialysates with potassium concentrations of 2 mEq/L, 1 mEq/L, or 0 mEq/L were compared. Each patient (exceptions noted in text) was studied once at each bath potassium concentration. Cardiac rhythm was recorded by Holter monitor during and for six hours following dialysis. Single PVCs and APCs were common with all potassium concentrations. Only one patient had high-grade ventricular ectopy. It was seen with each of the three potassium concentrations, but was most severe with the potassium-free dialysate. The potassium-free dialysate removed significantly more potassium (78.5 +/- 2.6 mEq) than the 1-K dialysate (62.9 +/- 5.1 mEq) or the 2-K dialysate (50.6 +/- 6 mEq), and the 1-K dialysate removed significantly more potassium than the 2-K dialysate. There were small but significant differences in serum potassium concentrations with the three different dialysates. It was concluded that (1) in all but one of our patients potassium-free dialysate did not produce new ectopy; (2) potassium-free dialysate was 24% more effective than 1-K dialysate and 50% more effective than 2-K dialysate in removing body potassium; and (3) 1-K dialysate was 20% more effective than 2-K dialysate in removing body potassium.
authors.affiliation: Renal Division, Michael Reese Hospital and Medical Center, Chicago, IL 60616.
authors.forename: S
authors.initials: S
authors.lastname: Hou
authors.forename: P A
authors.initials: PA
authors.lastname: McElroy
authors.forename: J
authors.initials: J
authors.lastname: Nootens
authors.forename: M
authors.initials: M
authors.lastname: Beach
mesh_terms: D000328:Adult; D002318:Cardiovascular Diseases / Q000139:chemically induced / Q000517:prevention & control*; D015314:Dialysis Solutions / Q000009:adverse effects; D004562:Electrocardiography; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008875:Middle Aged; D008991:Monitoring, Physiologic; D011188:Potassium / Q000009:adverse effects / Q000097:blood; D006435:Renal Dialysis; D012449:Safety
chemical_list: D015314:Dialysis Solutions; D011188:Potassium